violation – cannabis.co.nz

May 5, 20228, analysis, analytics, business, cannabidiol, cannabis, cbd, claim, compliance, consumer, cure, Delta, delta-8 THC, delta-8-tetrahydrocannabinol, delta-9 tetrahydrocannabinol, delta-9-THC, Dispensaries & Retail, drug, Edibles & Processing, FD&C act, FDA, Federal, government, growing, illegal, industry, lab, label, laboratories, laboratory, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, marketing, medical, medicine, misbranded, prevent, product, Quality, recreational, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, treat, unapproved, update, violate, violation, warning

FDA Issues First Warning Letters for Delta-8 THC

In an unprecedented move, the U.S. Food & Drug Administration (FDA) has issued warning letters today to companies selling products containing delta-8 […]

November 6, 2021analysis, analytics, assess, assessing, business, cannabis, chemical, citation, compliance, Concentrates & Extracts, consumer, cultivation, Cultivation & Growing, Edibles & Processing, explosion, extraction, Federal, government, growing, hazard, identification, identify, incident, industry, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Operations, OSHA, Pesticide, PPE, process, product, Quality, recreational, regulation, regulations, regulatory, risk, safe, safety, state, violation, worker, workplace

The Path Forward to a Safer Cannabis Industry

Two decades ago, California became the first state to legalize the medical use of cannabis. In 2021, medical use of cannabis is […]

March 26, 2021Act, active, advertised, advertising, analysis, analytics, and Cosmetic, approval, business, cannabidiol, cannabis, cbd, compliance, consumer, Dispensaries & Retail, drug, FDA, FDA food safety challenge, Federal, food, GMP, good manufacturing practice, government, growing, Husch Blackewell, inactive, industry, ingredient, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, marketing, medical, medicine, NDA, New Drug Application, nonprescription, OTC, prescription, product, products, Quality, recreational, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, violation, warning

FDA Issues Warning Letters on Marketing and Sale of OTC CBD Products

The U.S. Food and Drug Administration (FDA) issued warning letters this month to two companies concerning the marketing and sale of over-the-counter (OTC) drug […]